Unexpected findings show that the body’s own immune system destroys retinal cells.
Glaucoma, a disease that afflicts nearly 70 million people worldwide, is something of a mystery despite its prevalence. Little is known about the origins of the disease, which damages the retina and optic nerve and can lead to blindness.
A new study from MIT and Massachusetts Eye and Ear has found that glaucoma may in fact be an autoimmune disorder. In a study of mice, the researchers showed that the body’s own T cells are responsible for the progressive retinal degeneration seen in glaucoma. Furthermore, these T cells appear to be primed to attack retinal neurons as the result of previous interactions with bacteria that normally live in our body.
The discovery suggests that it could be possible to develop new treatments for glaucoma by blocking this autoimmune activity, the researchers say.
“This opens a new approach to prevent and treat glaucoma,” says Jianzhu Chen, an MIT professor of biology, a member of MIT’s Koch Institute for Integrative Cancer Research, and one of the senior authors of the study, which appears in Nature Communications on Aug. 10.
Dong Feng Chen, an associate professor of ophthalmology at Harvard Medical School and the Schepens Eye Research Institute of Massachusetts Eye and Ear, is also a senior author of the study. The paper’s lead authors are Massachusetts Eye and Ear researchers Huihui Chen, Kin-Sang Cho, and T.H. Khanh Vu.
Genesis of glaucoma
One of the biggest risk factors for glaucoma is elevated pressure in the eye, which often occurs as people age and the ducts that allow fluid to drain from the eye become blocked. The disease often goes undetected at first; patients may not realize they have the disease until half of their retinal ganglion cells have been lost.
Most treatments focus on lowering pressure in the eye (also known as intraocular pressure). However, in many patients, the disease worsens even after intraocular pressure returns to normal. In studies in mice, Dong Feng Chen found the same effect.
“That led us to the thought that this pressure change must be triggering something progressive, and the first thing that came to mind is that it has to be an immune response,” she says.
To test that hypothesis, the researchers looked for immune cells in the retinas of these mice and found that indeed, T cells were there. This is unusual because T cells are normally blocked from entering the retina, by a tight layer of cells called the blood-retina barrier, to suppress inflammation of the eye. The researchers found that when intraocular pressure goes up, T cells are somehow able to get through this barrier and into the retina.
The Mass Eye and Ear team then enlisted Jianzhu Chen, an immunologist, to further investigate what role these T cells might be playing in glaucoma. The researchers generated high intraocular pressure in mice that lack T cells and found that while this pressure induced only a small amount of damage to the retina, the disease did not progress any further after eye pressure returned to normal.
Further studies revealed that the glaucoma-linked T cells target proteins called heat shock proteins, which help cells respond to stress or injury. Normally, T cells should not target proteins produced by the host, but the researchers suspected that these T cells had been previously exposed to bacterial heat shock proteins. Because heat shock proteins from different species are very similar, the resulting T cells can cross-react with mouse and human heat shock proteins.
To test this hypothesis, the team brought in James Fox, a professor in MIT’s Department of Biological Engineering and Division of Comparative Medicine, whose team maintains mice with no bacteria. The researchers found that when they tried to induce glaucoma in these germ-free mice, the mice did not develop the disease.
Human connection
The researchers then turned to human patients with glaucoma and found that these patients had five times the normal level of T cells specific to heat shock proteins, suggesting that the same phenomenon may also contribute to the disease in humans. The researchers’ studies thus far suggest that the effect is not specific to a particular strain of bacteria; rather, exposure to a combination of bacteria can generate T cells that target heat shock proteins.
One question the researchers plan to study further is whether other components of the immune system may be involved in the autoimmune process that gives rise to glaucoma. They are also investigating the possibility that this phenomenon may underlie other neurodegenerative disorders, and looking for ways to treat such disorders by blocking the autoimmune response.
“What we learn from the eye can be applied to the brain diseases, and may eventually help develop new methods of treatment and diagnosis,” Dong Feng Chen says.
Learn more: Study suggests glaucoma may be an autoimmune disease
The Latest on: Glaucoma
[google_news title=”” keyword=”glaucoma” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Glaucoma
- Surgery For Glaucoma: Expert Explains If Trabeculectomy Is A Major Surgery For This Conditionon May 8, 2024 at 10:51 pm
Trabeculectomy surgery establishes a fresh drainage route within the eye to reduce intraocular pressure thus averting vision impairment ...
- Common Questions About Cat Health Answered By Doctors.on May 8, 2024 at 9:52 pm
(increased pressure in the eye), uveitis (inflammation of the uvea), squinting or blinking (indicative of eye discomfort or pain), watery eyes (can signal allergies or blocked tear ducts), and eye ...
- Oluwatosin U. Smith, MD, talks about her love for research and educationon May 8, 2024 at 5:14 pm
McDonnell, MD, director of the Wilmer Eye Institute at Johns Hopkins University School of Medicine in Baltimore, Maryland, and Oluwatosin U. Smith, MD, partner, physician, and surgeon at the Glaucoma ...
- Does your ADHD medication increase your risk of glaucoma?on May 8, 2024 at 3:28 am
By Tarun Sai Lomte In a recent study published in Eye , researchers assessed the risks of open-angle glaucoma (OAG) and angle closure glaucoma (ACG) among users of attention-deficit/hyperactivity ...
- Visual Field Progression, Doubling Risk of Event Progression Associated With Density Loss in Optic Nerveon May 7, 2024 at 5:00 pm
Glaucoma is best managed through the early detection of visual field progression. OCTA can provide images of the retinal microvasculature, but its usage in glaucoma evaluation is still being ...
- Polygenic Risk Score Called Useful to Diagnose Open-Angle Glaucomaon May 7, 2024 at 5:00 pm
A risk score incorporating genetic variants for open-angle glaucoma is accurate enough to help with diagnosis of the condition, an interim study reveals. Although hundreds of genetic changes are ...
- ARVO 2024: Researchers detail novel glaucoma shunton May 7, 2024 at 9:26 am
In a presentation at the Association for Research in Vision and Ophthalmology 2024 annual meeting in Seattle novel shunt could potentially improve postoperative IOP control and lower the risk of ...
- Why Glaucoma Being Called 'The Silent Thief Of Sight'?on May 5, 2024 at 1:50 am
Glaucoma is often referred to as the "silent thief of sight" because it typically progresses slowly and without noticeable symptoms until significant vision loss occurs. As one of ...
- Eye Drops Or Laser Surgery? Expert Explains Which Is A Better Treatment For Glaucomaon May 2, 2024 at 11:55 pm
Have you heard about an eye condition that can lead to irreversible vision loss if not treated on time? Glaucoma is a group of eye diseases that can lead to vision loss and blindness through damage to ...
via Bing News